Corbus Pharmaceuticals Holdings Inc (CRBP)

Feb 04, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Feb 04, 2025

Feb 04, 2025

Chief Financial Officer Moran Sean F. was granted 27,500 shares, increasing direct ownership by 57% to 76,105 units (SEC Form 4) - Quantisnow

Feb 04, 2025

Feb 03, 2025

CRBP stock touches 52-week low at $9.26 amid market challenges - MSN

Feb 03, 2025

Feb 03, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch

Feb 03, 2025

Feb 03, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Stock Position Lifted by JPMorgan Chase & Co. - Defense World

Feb 03, 2025

Feb 02, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Sees Significant Decline in Short Interest - MarketBeat

Feb 02, 2025

Jan 31, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch

Jan 31, 2025

Jan 30, 2025

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Jan 30, 2025

Jan 30, 2025

(CRBP) Proactive Strategies - Stock Traders Daily

Jan 30, 2025

Jan 29, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Jan 29, 2025

Jan 28, 2025

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference - GlobeNewswire

Jan 28, 2025

Jan 28, 2025

Corbus Pharmaceuticals Holdings Inc. stock rises Tuesday, still underperforms market - MarketWatch

Jan 28, 2025

Jan 28, 2025

Exclusive: Corbus Pharmaceuticals Reveals Strategic Vision at Elite Biotech Conference - StockTitan

Jan 28, 2025

Jan 25, 2025

CRBP stock touches 52-week low at $10.43 amid market fluctuations - Investing.com Australia

Jan 25, 2025

Jan 24, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch

Jan 24, 2025

Jan 23, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch

Jan 23, 2025

Jan 18, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Down 9.1% in December - MarketBeat

Jan 18, 2025

Jan 18, 2025

Short Interest in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Decreases By 9.1% - Defense World

Jan 18, 2025

Jan 16, 2025

Brokerages Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Target Price at $62.00 - Defense World

Jan 16, 2025

Jan 14, 2025

Corbus Pharmaceuticals (NASDAQ:CRBP) Upgraded to Sell at StockNews.com - Defense World

Jan 14, 2025

Jan 13, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives $62.00 Average Price Target from Brokerages - MarketBeat

Jan 13, 2025

Jan 08, 2025

Dermatomyositis Market to Show Remarkable Growth Trends from - openPR

Jan 08, 2025

Jan 08, 2025

Corbus Pharmaceuticals Holdings, Inc. Announces Clinical Data for CRB-701 from Western Dose Escalation Study to Be Presented at ASCO GU 2025 - Marketscreener.com

Jan 08, 2025

Jan 08, 2025

Corbus Pharmaceuticals Announces that Clinical Data for - GlobeNewswire

Jan 08, 2025

Jan 08, 2025

Corbus Pharmaceuticals to Present CRB-701 Cancer Drug Trial Data at ASCO GU 2025 Symposium - StockTitan

Jan 08, 2025

Jan 08, 2025

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025 - The Manila Times

Jan 08, 2025

Jan 07, 2025

Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Jan 07, 2025

Jan 06, 2025

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Jan 06, 2025

Jan 05, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by Geode Capital Management LLC - Defense World

Jan 05, 2025

Jan 03, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Sees Large Growth in Short Interest - Defense World

Jan 03, 2025

Jan 01, 2025

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Short Interest Update - MarketBeat

Jan 01, 2025

Dec 29, 2024

How to Take Advantage of moves in (CRBP) - Stock Traders Daily

Dec 29, 2024

Dec 26, 2024

State Street Corp Buys 153,243 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Dec 26, 2024

Dec 26, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Shares Acquired by State Street Corp - MarketBeat

Dec 26, 2024

Dec 22, 2024

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Stock Holdings Boosted by Fmr LLC - Defense World

Dec 22, 2024

Dec 22, 2024

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Target Price at $62.00 - Defense World

Dec 22, 2024

Dec 19, 2024

Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch

Dec 19, 2024

Dec 19, 2024

Analysts Set Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) PT at $62.00 - MarketBeat

Dec 19, 2024

Dec 18, 2024

(CRBP) Investment Report - Stock Traders Daily

Dec 18, 2024

Dec 17, 2024

Mizuho remains bullish on Corbus stock, sees encouraging outlook for Nectin-4 ADC - Investing.com Canada

Dec 17, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Buys 64,800 Shares of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - MarketBeat

Dec 17, 2024

Dec 17, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) - Defense World

Dec 17, 2024